Brand Index Methodology
The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.
Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.
Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been shoring up its future earnings through a series of strategic acquisitions, development of its alternate care business, and promotion of its specialty drug assets. In late 2015 the company acquired Cordis, naviHealth, and Harvard Drug; it spent much of 2016 integrating them, with a 19% increase in annual revenue to show for it. The company’s pharmaceutical segment endured ongoing profit pressures for generics and the loss of a major customer but lessened the blows with new drug launches and sales growth; its medical segment grew because of acquisitions. The partnerships and purchases are a way for Cardinal Health to snag a greater share of the medical products sold to hospitals, physicians, and ambulatory centers. The company was founded in 1979 and is headquartered in Dublin, Ohio.
CEO
Michael C. Kaufmann
CEO Title
Chairman & Chief Executive Officer
Sector
Wholesalers
Industry
Wholesalers: Health Care
HQ Location
Dublin, OH
Website
Years on Fortune 500 List
23
Employees
37,300
SPONSOR CENTER
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | $121,546 | 18.5% |
| Profits ($M) | $1,427.0 | 17.4% |
| Assets ($M) | $34,122 | |
| Total Stockholder Equity ($M) | $6,554 | |
| Market Value — as of March 31, 2017 ($M) | $25,725 |
| Profit as % of Revenues | 1.2% | |
| Profits as % of Assets | 4.2% | |
| Profits as % of Stockholder Equity | 21.8% |
| Earnings Per Share ($) | 4.32 | |
| EPS % Change (from 2015) | 19.3% | |
| EPS % Change (5 year annual rate) | 9.7% | |
| EPS % Change (10 year annual rate) | 6.4% |
| Total Return to Investors (2016) | -17.7% | |
| Total Return to Investors (5 year, annualized) | 14.5% | |
| Total Return to Investors (10 year, annualized) | 6.4% |
- Previous Close:
- Market Cap: NaNB
- Next Earnings Date:
- High:
- Low:
- 52 Week High:
- 52 Week Low:
- 52 Week Change %: 0.00
- P/E Ratio: n/a
- EPS:
- Dividend Yield: n/a
News about Cardinal Health
Attorney General Jeff Sessions announced a "statement of intent" to prop up suits against opioid makers and distributors.
Sparking a selloff in the shares of a host of health care-related companies.
Amazon is reportedly talking to drug firms.
The special Sino Saturday edition of CEO Daily.
Corporate governance matters, too.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc.. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions